freelance entreprenuer

Formerly Merck Research Labs

Formerly Abmaxis Inc.

freelance entreprenuer

Therapeutic antibody engineering and other commercial value of protein engineering

Published and Granted US patents:
1. Compositions and methods for generating chimeric heteromultimers. US patent, US6,833,441.
2. Compositions and methods for generating chimeric heteromultimers. US patent, US7,429,652.
3. Adapter-directed display systems. US patent, US7,175,983.
4. Structure-based selection and affinity maturation of antibody library. US Patent, US7,117,096.
5. Humanized antibodies against vascular endothelial growth factor. US Patent, US7,667,004.
6. Anti-CD26 antibodies and methods of use thereof. US Patent, US7,462,698.

Published Patent Applications:
1. Structure-based selection and affinity maturation of antibody library. Patent application, US 20020177170
2. Adapter-directed display systems. Patent application, US20030104355.
3. Compositions and methods for generating chimeric heteromultimers. Patent application, US20030027247
4. Generation and affinity maturation of antibody library in silico. Patent application, US20030022240
5. Humanized antibodies against vascular endothelial growth factor. Patent application, US20040133357A1.
6. Generation and selection of protein library in silico. Patent application, US20040010376
7. Compositions and methods for generating chimeric heteromultimers. Patent application, US20050009139
8. Adaptor-directed helper systems. Patent application, US 20060281181A1.
9. Generation and selection of protein library in silico. Patent application, US20070037214A1.
10. Structure-based selection and affinity maturation of antibody library. Patent application, US20070037217A1.
11. Anti-CD26 antibodies and methods of use thereof. Patent application, US20070105771.
12. Cross-Species and multi-species display systems. Patent application, WO/2007/130520.
13. Cross-Species and Multi-Species Display Systems. Patent application, US20090082221
14. Anti-CD26 antibodies and methods of use thereof. Patent application, US20090136523
15. 1D05 PCSK9 antagonists. Patent application, US20090246192.
16. 1B20 PCSK9 antagonists. Patent application, US20090232795.
17. Eukaryotic cell display systems. Patent application, US20090163379

The above list does not include all additional divisional and subsidiary international filing and the on-going prosecutions in multiple countries. Multiple unpublished pending applications are also not listed.